Nicotine treatment of mild cognitive impairment
A 6-month double-blind pilot clinical trial
Make Comment
See Comments
Share
This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
AAN Members
AAN Non-Member Subscribers
Purchase access
For assistance, please contact:
AAN Members (800) 879-1960 or (612) 928-6000 (International)
Non-AAN Member subscribers (800) 638-3030 or (301) 223-2300 option 3, select 1 (international)
Sign Up
Information on how to subscribe to Neurology and Neurology: Clinical Practice can be found here
Purchase
Individual access to articles is available through the Add to Cart option on the article page. Access for 1 day (from the computer you are currently using) is US$ 39.00. Pay-per-view content is for the use of the payee only, and content may not be further distributed by print or electronic means. The payee may view, download, and/or print the article for his/her personal, scholarly, research, and educational use. Distributing copies (electronic or otherwise) of the article is not allowed.
Disputes & Debates: Rapid online correspondence
- Editor's Note from Richard Kryscio, Associate Editor of Biostatistics:
- Richard J. Kryscio
Published April 04, 2012 - Reply from the authors
- Paul A. Newhouse, Director
- Diantha Howard, University of Vermont
Published February 09, 2012 - Control over type I error in this study??
- Michael Gold, Chief Medical Officer
Published February 07, 2012
You May Also be Interested in
- ArticleApathy rating scores and β-amyloidopathy in patients with Parkinson disease at risk for cognitive declineZhi Zhou, Martijn L.T.M. Müller, Prabesh Kanel, et al.November 15, 2019
- WriteClick: Editor's ChoiceNicotine Treatment of Mild Cognitive Impairment: a 6-Month Double-Blind Pilot Clinical TrialAuthor ResponseEditor's Note from Associate Editor of BiostatisticsMichael Gold, Paul A. Newhouse, Richard J. Kryscio, et al.June 04, 2012
- ArticleSafety and efficacy of galantamine in subjects with mild cognitive impairmentB. Winblad, S. Gauthier, L. Scinto, et al.March 05, 2008
- ArticleFactors associated with cognitive evaluations in the United StatesVikas Kotagal, Kenneth M. Langa, Brenda L. Plassman, et al.November 26, 2014
- ArticleAPOE polymorphisms and cognitive functions in patients with brain tumorsDenise D. Correa, Jaya Satagopan, Raymond E. Baser, et al.June 18, 2014